Genome‐wide investigation of a neuropathological cohort offers novel insights in the genetic risk underlying hallmark and co‐morbid lesions implicated in Alzheimer’s disease

Implementing phenotypic information on neuropathological lesions in a hypothesis-free genome-wide investigation as a preliminary screening rendered genome-wide significant and suggestive loci which can contribute to a deeper understanding of the individual lesions observed in AD. From our preliminary results we observe the benefits of accurate phenotyping on GWAS power. Despite small sample size, we managed to detect genome-wide significant associations for AD-related lesions by eliminating phenotypic heterogeneity. Associated loci will be subjected to gene prioritization and functional validation analysis to determine the causal risk genes. For more commonly investigated hallmark lesions, replication analysis will be performed in publicly available cohorts.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.092254
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genome‐wide investigation of a neuropathological cohort offers novel insights in the genetic risk underlying hallmark and co‐morbid lesions implicated in Alzheimer’s disease

Alicja Ronisz, Philip Van Damme, Klara Gawor, Kristel Sleegers et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Genome‐wide investigation of a neuropathological cohort offers novel insights in the genetic risk underlying hallmark and co‐morbid lesions implicated in Alzheimer’s disease

Alicja Ronisz, Philip Van Damme, Klara Gawor, Kristel Sleegers, Dietmar Rudolf Thal, Marta J. Koper, Fahri Küçükali, Markus Otto, Rik R. Vandenberghe, Christine A. F. Von Arnim, Jasper Van Dongen, Celeste Laureyssen
article en

Abstract

Implementing phenotypic information on neuropathological lesions in a hypothesis-free genome-wide investigation as a preliminary screening rendered genome-wide significant and suggestive loci which can contribute to a deeper understanding of the individual lesions observed in AD. From our preliminary results we observe the benefits of accurate phenotyping on GWAS power. Despite small sample size, we managed to detect genome-wide significant associations for AD-related lesions by eliminating phenotypic heterogeneity. Associated loci will be subjected to gene prioritization and functional validation analysis to determine the causal risk genes. For more commonly investigated hallmark lesions, replication analysis will be performed in publicly available cohorts.

Alzheimer s & DementiaVol. 20(S1)
University of Antwerp (BE), Universitair Ziekenhuis Leuven (BE), Universitätsmedizin Göttingen (DE), VIB-UAntwerp Center for Molecular Neurology (BE), VIB-KU Leuven Center for Brain & Disease Research (BE), University Hospital Ulm (DE), KU Leuven (BE)
Openalex Percentile: Top 65%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.